# Expressive Disclosure and Colorectal Cancer

> **NCT00853203** · — · UNKNOWN · sponsor: **M.D. Anderson Cancer Center** · enrollment: 174 (estimated)

## Conditions studied

- Colorectal Cancer

## Interventions

- **BEHAVIORAL:** Interviews
- **BEHAVIORAL:** Questionnaires
- **OTHER:** Electronically Activated Recorder (EAR)
- **BEHAVIORAL:** Group Meetings
- **BEHAVIORAL:** Written Materials

## Key facts

- **NCT ID:** NCT00853203
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-01
- **Primary completion:** 2021-08
- **Final completion:** 2021-08
- **Target enrollment:** 174 (ESTIMATED)
- **Last updated:** 2020-12-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00853203

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00853203, "Expressive Disclosure and Colorectal Cancer". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00853203. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*